CME Group Inc - Ordinary Shares - Class A

CME Group Inc - Ordinary Shares - Class A

CME - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$113.31B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
CME Group Inc - Ordinary Shares - Class ACME Group Inc - Ordinary Shares - Class A25.93.55%17%16.70.1

Earnings Call Q3 2026

October 21, 2026 - AI Summary

Record trading demand & balance-sheet-friendly growth (good): - Q3’26 average daily volume (ADV): 29.4m contracts, the highest third-quarter on record, +16% YoY. - Broad-based growth across all 6 asset classes with double-digit YoY volume increases in every asset class. - Financial & commodity products volume: each +16% YoY. - Quarter-end open interest (OI): 128m contracts; today >133m, and OI continues to grow in October (signals healthy participation and margin of safety for volume).
Strong financial results + capital returns (good): - Revenue: $1.7bn, +13% YoY, record third-quarter revenue. Market data revenue: +20% YoY (and $243m quarterly record for market data). - Adjusted operating income: $1.2bn, +15% YoY; adjusted operating margin: 69.4%. - Adjusted diluted EPS: $3.02, +13% YoY; adjusted net income margin: 62.4%. - Shareholder returns: returned ~$1bn in Q3 ($465m regular dividends + $524m share repurchases). - YTD (first 3 quarters): revenues +9%, adjusted EPS +11%.
Management outlook for Q4 and year (good): - Q4 volume running ahead of prior record: management says Q4 volume is surpassing last year’s record Q4 by ~17%. - YTD through 3Q: ~12% ahead of last year’s record volume. - Stated focus: keep delivering deep liquidity and maximize customer capital efficiencies, supporting continued earnings strength in what they describe as a volatile macro environment.

Exclusive for Stockcircle Pro members

Sign upSign Up
$314.56

Target Price by Analysts

1.1% downsideCME Group Target Price DetailsTarget Price
$416.88

Current Fair Value

31.1% upside

Undervalued by 31.1% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$113.31 Billion
Enterprise Value$114.54 Billion
Annual dividend$11.30
Dividend yield3.55%
Earnings per Share$11.18
Beta0.27
Outstanding Shares358,019,000

Return

Return on Equity16.57%ROE
Return on Assets2.29%
Return on Invested Capital2.67%

Valuation & Multiples

P/E Ratio25.94P/E Ratio
PEG182.7PEG
Price to Sales16.74Price to Sales
Price to Book Ratio4.3Price to Book Ratio
Enterprise Value to Revenue16.43
Enterprise Value to EBIT22.31
Enterprise Value to Net Income26
Total Debt to Enterprise0.03
Debt to Equity0.13Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
October 28, 2026
EPS Estimate
$2.96
Consensus analyst estimate
Revenue Estimate
$1.69 B
Consensus analyst estimate

Next Earnings Call

Expected Date
February 3, 2027
EPS Estimate
$3.01
Consensus analyst estimate
Revenue Estimate
$1.76 B
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 39.29, the ratio is above 1, so institutions hold more puts than calls. That is a more cautious stance.

Put/Call Ratio39.2857▲ 3822.60%
Total Calls1,400▼ 99.93%
Total Puts55,000▼ 97.26%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %18.70%▼ 71.40%
Total Invested$17.66B▼ 75.36%
Investors Holding938▼ 837.00%

About CME Group Inc

3,875 employees
CEO: Terrence Duffy

CME Group Inc., established in Chicago in 1898, operates global marketplaces for the exchange of futures and options contracts. The company provides a wide array of products, encompassing interest rates, equity indexes, foreign exchange,...

CME Group Insider Information FAQ

Stockcircle tracks 15 top investors with a current 13F position in CME Group. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 1 top investor increased or opened positions and 4 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 2 open-market insider purchases and 10 open-market insider sales for CME Group in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Stockcircle lists 5 politician trade disclosures tied to CME Group in the last twelve months, drawn from periodic financial disclosure reports. 4 politicians traded CME Group in the past year.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.